<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">radiology</journal-id><journal-title-group><journal-title xml:lang="ru">Радиология — практика</journal-title><trans-title-group xml:lang="en"><trans-title>Radiology - Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2713-0118</issn><publisher><publisher-name>Центральный научно-исследовательский институт лучевой диагностики</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">radiology-62</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Кальцинаты типа фрагментированных слепков как потенциальный независимый фактор прогноза при протоковой карциноме in situ молочной железы</article-title><trans-title-group xml:lang="en"><trans-title>Fragmented Casting Calcifications as a Potential Independent Prognostic Factor in Ductal Adenocarcinoma in Situ of the Breast</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пучкова</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Puchkova</surname><given-names>O. S.</given-names></name></name-alternatives><email xlink:type="simple">helgasoul@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицын</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitsyn</surname><given-names>V. E.</given-names></name></name-alternatives><email xlink:type="simple">vsini@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богомазова</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogomazova</surname><given-names>S. Yu.</given-names></name></name-alternatives><email xlink:type="simple">bogomazova@list.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мершина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shirokiy</surname><given-names>V. P.</given-names></name></name-alternatives><email xlink:type="simple">Elena_mershina@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Широкий</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Mershina</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">shirokiy_v@mail.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баженова</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazhenova</surname><given-names>D. A.</given-names></name></name-alternatives><email xlink:type="simple">bazhenova.darya@gmail.com</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ненайденко</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nenaydenko</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">nenajdenko@gmail.com</email><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ильинская больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Il’inskiy Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Московский государственный университет им. М. В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАУ «Лечебно-реабилитационный центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Center of Treatment and Rehabilitation Ministry of Healthcare</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБОУ ВО «Московский государственный университет им. М. В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Center of Treatment and Rehabilitation Ministry of Healthcare</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГАУ «Лечебно-реабилитационный центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>МНОЦ «Университетская клиника ФГБОУ ВО «Московский государственный университет им. М. В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>University Clinic, Medical Research and Education Center of Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff xml:lang="ru" id="aff-7"><institution>ФГБОУ ВО «Московский государственный университет им. М. В. Ломоносова»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2019</year></pub-date><volume>0</volume><issue>4</issue><fpage>30</fpage><lpage>39</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пучкова О.С., Синицын В.Е., Богомазова С.Ю., Мершина Е.А., Широкий В.П., Баженова Д.А., Ненайденко Е.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Пучкова О.С., Синицын В.Е., Богомазова С.Ю., Мершина Е.А., Широкий В.П., Баженова Д.А., Ненайденко Е.В.</copyright-holder><copyright-holder xml:lang="en">Puchkova O.S., Sinitsyn V.E., Bogomazova S.Y., Shirokiy V.P., Mershina E.A., Bazhenova D.A., Nenaydenko E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.radp.ru/jour/article/view/62">https://www.radp.ru/jour/article/view/62</self-uri><abstract><p>Целью исследования явилась оценка потенциальной возможности использования рентгенологической семиотики рака молочной железы (РМЖ) как предиктора отдаленных результатов лечения. В настоящем исследовании приняли участие 112 пациенток в возрасте 29-89 лет с протоковой карциномой молочной железы. Пациенты были выделены в группу на основании современной рентген-гистологической классификации РМЖ и рентгенологического типа строения молочной железы, предложенных Л. Табаром. Всем пациентам была выполнена трепанобиопсия с последующим гистологическим исследованием. В предоперационном периоде выполнялось МРТ молочной железы с контрастным усилением. Был проведен анализ данных и поиск корреляций между рентгенологическими характеристиками протокового РМЖ, степенью злокачественности, возрастом, наличием периопухолевого отека при МР-маммографии. Согласно проведенному анализу, наиболее молодой возраст в группе протоковых карцином определялся при кальцинатах типа фрагментированного слепка - 29 лет. В 33 % клинических наблюдений встречался 4-й тип рентгенологичского строения, 80 % из которых были представлены на рентгенограммах кальцинатами типа фрагментированных слепков. В 11 % клинических наблюдений был выявлен 5-й тип рентгенологического строения молочной железы. Доля пациенток с высокой степенью злокачественности в группе пациенток с кальцинатами типа фрагментированного слепка составляла 80%. Только в группе пациентов с кальцинатами типа фрагментированных слепков в 51 % наблюдений отмечался периопухолевй отек на МР-маммографии. В других группах зависимость между рентгенологическими характеристиками опухоли и наличием отека выявлена не была. Таким образом, кальцинаты типа фрагментированного слепка (fragmented casting type) являются патогномоничным признаком низкодифференцированного протокового РМЖ, возникающего в более молодом возрасте, ассоциированного c 4-м типом строения молочной железы, а также являются предиктором наличия периопухолевого отека при МР-маммографии и могут быть рассмотрены как потенциальный независимый отрицательный прогностический фактор прогноза.</p></abstract><trans-abstract xml:lang="en"><p>The aim of this study was to determine the potential role of mammographic features of breast cancer, as a possible predictor of long-term outcome. 112 breast cancer patients were included in the study. Pathologic findings on mammography were assessed using the modern classification of L. Tabar. All patients underwent a core biopsy with subsequent histological examination. In the preoperative period, breast MRI with contrast enhancement was performed. An analysis of the data and the search for correlations between the radiographic characteristics breast cancer, the tumor grade and presence of peritumoral edema on breast MRI was performed. According to the analysis, the youngest age in the group of ductal adenocarcinomas was determined in patients with fragmented casting calcifications - 29 years. In the group of ductal carcinomas, in 33 % of cases were observed mammographic pattern 4 according to classification of L. Tabar and in 11 % of cases there was a pattern 5, while in the group of patients with fragmented casting calcifications pattern 4 was detected in 80 % of clinical observations. The proportion of patients with a high Grade tumors in the casting type was 80 %. Only in the group of patients with fragmented castings calcifications in 51 % of cases peritumoral edema on the breast MRI was observed. Fragmented casting type calcifications are a pathognomonic sign of a low-grade, ductal adenocarcinoma of the breast that occurs at a younger age and associated with the pattern 4 of breast structure by L. Tabar classification and also a predictor of peritumoral edema on breast MRI, thus can be an independent negative prognostic factor.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рентгенологическая плотность структуры</kwd><kwd>маммография</kwd><kwd>протоковая карцинома in situ</kwd><kwd>периопухолевый отек</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Breast Density</kwd><kwd>Mammography</kwd><kwd>Ductal Carcinoma in Situ</kwd><kwd>Peritumoral Oedema</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lakhani S., Ellis I., Schnitt S. et al. WHO classification of tumours of the breast. 4th ed. Lyon: IARC Press, 2012.</mixed-citation><mixed-citation xml:lang="en">Lakhani S., Ellis I., Schnitt S. et al. WHO classification of tumours of the breast. 4th ed. Lyon: IARC Press, 2012.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">McCann. Mammographic prediction of early breast cancer survival // J. Breast Cancer Res. 2000. V. 2.</mixed-citation><mixed-citation xml:lang="en">McCann. Mammographic prediction of early breast cancer survival // J. Breast Cancer Res. 2000. V. 2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Qi X., Chen A., Zhang P. et al. Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery // Oncol. Lett. 2017. V. 14. № 1. P. 79-88.</mixed-citation><mixed-citation xml:lang="en">Qi X., Chen A., Zhang P. et al. Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery // Oncol. Lett. 2017. V. 14. № 1. P. 79-88.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Reszec J., Hermanowicz A., Rutkowski R., et al. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema // Biomed. Res. Int. 2015. P. 8.</mixed-citation><mixed-citation xml:lang="en">Reszec J., Hermanowicz A., Rutkowski R., et al. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema // Biomed. Res. Int. 2015. P. 8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart B. W., Wild C. P. et al. World cancer report 2014. Lyon: International agency for Research on Cancer, 2014.</mixed-citation><mixed-citation xml:lang="en">Stewart B. W., Wild C. P. et al. World cancer report 2014. Lyon: International agency for Research on Cancer, 2014.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Chen T. H., Hsu C. Y. et al. Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review // J. Med. Screen. 2016. V. 24. № 1. P. 27-33.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Chen T. H., Hsu C. Y. et al. Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review // J. Med. Screen. 2016. V. 24. № 1. P. 27-33.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Tot T., Peter B. D. Prostate and Breast: Brother and Sister Organs V. I. 2014. 64 p.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Tot T., Peter B. D. Prostate and Breast: Brother and Sister Organs V. I. 2014. 64 p.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Tot T., Peter B. D. Ductal adenocarcinoma of the breast (DAB) 2014. V. III. Part 1. 64 p.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Tot T., Peter B. D. Ductal adenocarcinoma of the breast (DAB) 2014. V. III. Part 1. 64 p.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Dean P. B., Yen A. M. et al. A proposal to unify the classification of breast and prostate cancers based on the anatomic site of cancer origin and on long-term patient outcome // Breast Cancer (Auckl). 2014. V. 8. P. 15-38.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Dean P. B., Yen A. M. et al. A proposal to unify the classification of breast and prostate cancers based on the anatomic site of cancer origin and on long-term patient outcome // Breast Cancer (Auckl). 2014. V. 8. P. 15-38.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wu C. X., Lin G. S., Lin Z. X., et al. Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma // World J. Surg. Oncol. 2015. V. 13. P. 97.</mixed-citation><mixed-citation xml:lang="en">Wu C. X., Lin G. S., Lin Z. X., et al. Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma // World J. Surg. Oncol. 2015. V. 13. P. 97.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
